| Bonnie Orth, PHARM D | |
|
3051 Cahill Main, Fitchburg, WI 53711-7109 | |
| (608) 661-7220 | |
| (608) 661-7216 |
| Full Name | Bonnie Orth |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3051 Cahill Main, Fitchburg, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518144476 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 13503-040 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bonnie Orth, PHARM D 3051 Cahill Main, Fitchburg, WI 53711-7109 Ph: (608) 661-7220 | Bonnie Orth, PHARM D 3051 Cahill Main, Fitchburg, WI 53711-7109 Ph: (608) 661-7220 |
News Archive
The prevalence of benign thyroid nodules is high and there are certain ultrasound features, suggesting malignancy, that can help radiologists determine whether or not a biopsy is needed, according to a study performed at the University of California San Francisco Medical Center, San Francisco, CA.
Researchers suggest consumers are not willing to spend money on insurance in the busy fall season as they plan for the holidays so sign-ups in the spring after tax returns are received might be better. Also, a look at consumers' reluctance to shop for insurance
Children who are exposed to secondhand smoke are more likely to need intensive care and intubation when hospitalized with influenza, according to new research by the University of Rochester Medical Center presented today at the Pediatric Academic Society meeting in Denver. The children also had longer hospital stays.
The presence of the human high-risk papillomavirus in the diagnosis of invasive cervical cancer is linked to a greatly improved prognosis compared with if high-risk HPV cannot be identified in the tumor, researchers at Karolinska Institutet in Sweden report in the scientific journal PLOS Medicine.
Genzyme, a Sanofi company, announced today that the U.S. Food and Drug Administration (FDA) has approved AUBAGIO (teriflunomide) as a new once-daily, oral treatment indicated for patients with relapsing forms of multiple sclerosis (MS).
› Verified 1 days ago
Jake Lehmann, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2931 S Fish Hatchery Rd, Fitchburg, WI 53711 Phone: 608-277-0087 | |
Mrs. Katie J Salzman, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6321 Mckee Rd, T2106, Fitchburg, WI 53719 Phone: 608-819-1523 | |
Mr. Robert Charles Muller, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3051 Cahill Main, Fitchburg, WI 53711 Phone: 608-661-7220 Fax: 608-661-7216 | |
Brian Lu, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2931 S Fish Hatchery Rd, Fitchburg, WI 53711 Phone: 608-277-0087 | |
Austin James Stolze, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2920 Fitchrona Rd, Fitchburg, WI 53719 Phone: 608-273-5122 | |
Bonny Kimball, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5152 Anton Dr, 213, Fitchburg, WI 53719 Phone: 608-217-4551 | |
Dr. Daniel Ricci, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3000 Cahill Main Ste 114, Fitchburg, WI 53711 Phone: 608-274-3784 Fax: 608-274-3780 |